Neuroleptic Malignant Syndrome
Although neuroleptic malignant syndrome is easily recognized in its classic full-blown form, it is often heterogeneous in onset, presentation, progression, and outcome(Addonizio et al. 1986; Caroff 2003; Caroff and Mann 1993; Rosebush and Stewart 1989; Strawn et al. 2007). The clinical features described below are those considered most important in making the diagnosis of neuroleptic malignant syndrome based on consensus recommendations(Gurrera et al. 2011).